April 2021 in “Journal of Investigative Dermatology” This review assesses platelet-rich plasma therapy for androgenic alopecia in women and found it may improve hair thickness and quality, but more studies are necessary to confirm its psychological benefits.
1 citations
,
August 2020 in “Food Research” This review discusses management strategies for androgenic alopecia using plant derivatives and highlights the need for prolonged efficacy but reports no new clinical findings.
7 citations
,
January 2020 in “Postepy Dermatologii I Alergologii” Oxidative stress plays a role in female pattern baldness, causing an imbalance between harmful and protective elements in the body.
April 2018 in “Journal of Investigative Dermatology” This review discusses recent studies on platelet-rich plasma (PRP) therapy for androgenic alopecia and found varied results; the authors highlight a need for more controlled trials to standardize treatment methods.
30 citations
,
December 2017 in “Medical Hypotheses” This review evaluates dihydrotestosterone's role in androgenic alopecia and proposes a model suggesting that chronic scalp tension and inflammation contribute to hair follicle miniaturization, identifying fibrosis, calcification, and tension as treatment targets.
December 2015 in “Vestnik dermatologii i venerologii” This article reviews studies on androgen hormone profiles in men with androgenetic alopecia and the effects of androgens and 5-alpha reductase on hair follicles, but provides no new findings.
15 citations
,
September 2014 in “JAMA Dermatology” This discussion highlights the use of minimal incision extraction for lipoma removal, noting that it is a favored technique among dermatologists due to its efficiency, despite some hesitance with larger lipomas.
March 2014 in “Medicina cutánea ibero-latino-americana” This review discusses the role of melatonin in skin and hair physiology, highlighting clinical evidence for its potential benefits in treating androgenetic alopecia, but does not report new results.
July 2013 in “e-Jurnal Medika Udayana” This article discusses the impact of estrogens on hair follicle growth in female pattern hair loss, noting their ability to increase anagen phase and suppress telogen phase, but reports no new clinical results.
This review discusses treatments for androgenic alopecia, noting that current options like finasteride and minoxidil are effective for only 10% of patients, thus highlighting the need for new therapies.
January 2008 in “Dermatology Online Journal” This review explores potential treatments for female androgenetic alopecia, noting that anti-hormonal therapies may be beneficial for some women, but emphasizes the need for further research and effective solutions.
January 2006 in “프로그램북(구 초록집)” 
165 citations
,
December 2002 in “Molecular and Cellular Endocrinology” This study found that finasteride improves scalp hair growth in men with male pattern hair loss by reducing scalp dihydrotestosterone levels, but it did not benefit postmenopausal women with female pattern hair loss.
12 citations
,
August 2000 in “Fertility and Sterility” Topical finasteride doesn't reduce DHT levels, hinting at an endocrine role in hair loss.
1 citations
,
March 1999 in “British journal of rheumatology” Adequate steroid treatment needed to limit bone loss in PMR patients.
January 1992 in “Juntendo Medical Journal” This article discusses male pattern baldness and the potential of androgen inhibitors, reporting on previous findings and the need for new preventive measures; it does not present new clinical results.
